findmyKOL

Eric Winer, MD

Enriched profile

Director, Yale Cancer Center; President and Physician-in-Chief, Smilow Cancer Hospital; Alfred Gilman Professor of Pharmacology and Professor of Medicine; Deputy Dean for Cancer Research, Yale School of Medicine · Yale School of Medicine

ORCID↗NPI↗
✓ Full profile
RegionNew Haven, CT · NortheastSpecialtyMedical OncologyFocusBreast Cancer Treatment Studies+4
Active KOLfindmyKOL type: NationalLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2021–2026

Eric Winer is Director, Yale Cancer Center; President and Physician-in-Chief, Smilow Cancer Hospital; Alfred Gilman Professor of Pharmacology and Professor of Medicine; Deputy Dean for Cancer Research, Yale School of Medicine at Yale School of Medicine. OpenAlex indexes 1,624 publications with 130,977 citations (h-index 171); ClinicalTrials.gov lists 20 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Medical Oncology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 14 Oct 2026

Eric P. Winer is Director, Yale Cancer Center at Yale School of Medicine / Yale Cancer Center / Smilow Cancer Hospital, New Haven, CT. The public record shows 1,624 publications with 130,977 citations (h-index 171), centered on Breast Cancer Treatment Studies, Advanced Breast Cancer Therapies, Cancer Treatment and Pharmacology. It also documents an investigator role on 8 registered clinical trials, 2 NIH-funded awards (2021–2026).

  • Most recent indexed publication: 2026 · Clinical cancer research
  • Top research focus: Breast Cancer Treatment Studies
  • 8 registered trials on ClinicalTrials.gov

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Breast Cancer7 trialsNeoplasm Metastasis1 trialBreast Neoplasms, Male1 trialCarcinoma, Intraductal, Noninfiltrating1 trial

Research focus

OpenAlex concept fingerprint
Breast Cancer Treatment StudiesAdvanced Breast Cancer TherapiesCancer Treatment and PharmacologyHER2/EGFR in Cancer ResearchCancer Genomics and Diagnostics

Drugs & molecules

across trials, industry payments and publications
Herceptingeneric · TrastuzumabClinical trials3Industry payments—Publications19PaclitaxelClinical trials1Industry payments—Publications10ChemotherapyClinical trials1Industry payments—Publications8CarboplatinClinical trials1Industry payments—Publications2CyclophosphamideClinical trials1Industry payments—Publications1DoxorubicinClinical trials1Industry payments—Publications1LapatinibClinical trials1Industry payments—Publications1Navelbinegeneric · VinorelbineClinical trials2Industry payments—Publications—2,2-Dimethyl-4-(chloromethyl)-1,3-dioxa-2-silacyclopentaneClinical trials1Industry payments—Publications—AntiandrogenClinical trials1Industry payments—Publications—BuparlisibClinical trials1Industry payments—Publications—DocetaxelClinical trials1Industry payments—Publications—

Works with

trial sponsors and companies reporting payments
Dana-Farber Cancer InstituteClinical trials2Industry payments—Pfizer Inc.Clinical trials—Industry payments2Puma Biotechnology, Inc.Clinical trials—Industry payments2AstraZeneca Pharmaceuticals LPClinical trials—Industry payments1Eric Winer, MDClinical trials1Industry payments—Gilead Sciences, Inc.Clinical trials—Industry payments1Jazz Pharmaceuticals Inc.Clinical trials—Industry payments1National Cancer Institute (NCI)Clinical trials1Industry payments—SanofiClinical trials1Industry payments—SOLTI Breast Cancer Research GroupClinical trials1Industry payments—SWOG Cancer Research NetworkClinical trials1Industry payments—Takeda Pharmaceuticals U.S.A., Inc.Clinical trials—Industry payments1UNC Lineberger Comprehensive Cancer CenterClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
1,624publications

Distinct works indexed by OpenAlex, matched via ORCID; 56 in PubMed.

130,977citations

Total citations across indexed works.

171h-index

Hirsch index (OpenAlex). i10-index 666.

Clinical & industry

trials, payments and federal funding
20clinical trials

Investigator role on registered studies.

View trials ↓
6companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
2NIH grants · 2021–2026

Federally funded research awards.

View funding ↓

Public positions

sourced statements on record

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 20 registered studies on ClinicalTrials.gov. The most recent:

All 20 trial records: search, sort and filter.Explore →

Industry payments

6 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

All 7 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2022)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    100%
    Kinase inhibitor100%
    Ibrance100%
    Part D<11 patients
Where care is delivered (Part B), 2021100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 14 Oct 2026

2 NIH research awards on record, funded 2021–2026 per NIH RePORTER. The latest:

All 84 award records: search, sort and filter.Explore →

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 56 publications: search, sort and filter.Explore →

Most-cited works

by citation count (OpenAlex)
  1. 01
    Breast Cancer Treatment
    4,866 citations2019
    doi.org ↗
  2. 02
    Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
    4,374 citations2018
    doi.org ↗
  3. 03
    Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
    3,722 citations2013
    doi.org ↗
  4. 04
    3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
    2,062 citations2016
    doi.org ↗
  5. 05
    Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
    2,014 citations2016
    doi.org ↗
All 1,624 cited works: search, sort and filter.Explore →

Network

Updated 14 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Nancy U. Lin450Ian E. Krop367Sara M. Tolaney337Ann H. Partridge236Clifford A. Hudis207Nikhil Wagle191Melissa E. Hughes179Lisa A. Carey168Harold J. Burstein162Erica L. Mayer153Adrienne G. Waks144William T. Barry140Ofir Cohen136Nabihah Tayob126Antonio C. Wolff102Hope S. Rugo101Gad Getz96Rachel A. Freedman96Elizabeth A. Mittendorf93Rinath Jeselsohn93Pedro Exman93Daniel G. Stover92Lorenzo Trippa89Nadine Tung84Seth A. Wander83Denise A. Yardley77Samuel S. Freeman77Romualdo Barroso‐Sousa77Vandana G. Abramson77Jorge E. Buendia-Buendia76Pingping Mao75Utthara Nayar75Donald A. Berry75Kailey J. Kowalski74Otto Metzger74Deborah Dillon74Beth Overmoyer74Levi A. Garraway73Viktor A. Adalsteinsson70Shoshana M. Rosenberg69

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/eric-winer-md-9c96eed0

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • Other

    insights.som.yale.edu/podcasts/health-veritas/eric-winer-cancer-doctors-journey

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →insights.som.yale.edu ↗
  • Other

    yalecancercenter.org/news/cancer-answers

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →yalecancercenter.org ↗
  • X / Twitter

    x.com/drericwiner

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗

Mentions by others

where others cite or feature them
  • X / Twitter

    Yale Cancer Center official X account (@YaleCancer) references Dr. Winer as Director

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
  • Connection.asco.org

    ASCO Connection: 'ASCO President-Elect Dr. Eric Winer Takes on New Leadership Role at Yale Cancer Center'

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →connection.asco.org ↗
  • Bcrf.org

    BCRF blog: 'BCRF Congratulates Dr. Eric P. Winer on Prestigious Appointment at Yale'

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bcrf.org ↗
  • Ynhhs.org

    Yale New Haven Health News: 'Eric P. Winer to lead Yale Cancer Center and Smilow Cancer Hospital'

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ynhhs.org ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Hematology/Oncology Fellowship

    Duke University School of Medicine

    1989
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • Board Certified

    Medical Oncology

    1989
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • Internal Medicine Residency

    Yale School of Medicine (1984-1987); Chief Resident, Yale New Haven Hospital

    1987
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • Board Certified

    Internal Medicine

    1987
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • M.D.

    Yale School of Medicine

    1983
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
  • B.A. in History and Russian/East European Studies

    Yale University

    1978
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
  • BA

    History and Russian/East European Studies, Yale University

    1978
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗

Editorial & leadership roles

journal and society appointments
  • Chair

    ASCO Board of Directors, 2023-2024

    2024
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • President

    American Society of Clinical Oncology (ASCO), 2022-2023

    2023
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • President

    American Society of Clinical Oncology (ASCO), 2022-2023

    2023
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
  • Chair

    NCI Breast Cancer Steering Committee

    2022
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.yale.edu ↗
  • Chair

    Scientific Advisory Board, Breast Cancer Research Foundation (BCRF)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bcrf.org ↗
  • Associate Editor

    JNCI: Journal of the National Cancer Institute

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →academic.oup.com ↗
  • Chair

    Scientific Advisory Board, Breast Cancer Research Foundation

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bcrf.org ↗
  • Co-chair

    NCI Breast Cancer Steering Committee

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →bcrf.org ↗
  • Panel member

    NCCN Breast Cancer Clinical Practice Guidelines

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →jnccn.org ↗
  • Former Chair

    Scientific Advisory Board, Susan G. Komen for the Cure

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Former Chief of Breast Oncology Program

    Dana-Farber Cancer Institute (1997-2021); former Professor of Medicine, Harvard Medical School; former Senior VP for Medical Affairs, Dana-Farber …

    2021
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
  • Formerly Chief

    Breast Oncology Program, Dana-Farber Cancer Institute (1997-2021); Professor of Medicine, Harvard Medical School

    2021
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
  • Chief Scientific Advisor

    Susan G. Komen for the Cure (prior long-term role, over a decade)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
  • Co-chair

    CALGB/Alliance Breast Cancer Committee

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
  • Medical Advisory Board Member

    Living Beyond Breast Cancer (LBBC)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →lbbc.org ↗
  • Chair

    Medical Oncology and Hematology, Yale School of Medicine / Smilow Cancer Hospital

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicine.yale.edu ↗
  • Medical Advisory Board

    Living Beyond Breast Cancer (LBBC)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lbbc.org ↗
  • Medical Advisory Board

    Acurion Health

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →acurionhealth.com ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.